Portal de Periódicos da CAPES

Anemia and Erythrocytes: Behavior and Prevalence 1 Year After Kidney Transplant

2020; Elsevier BV; Volume: 52; Issue: 4 Linguagem: Inglês

10.1016/j.transproceed.2020.01.053

1873-2623

Karla Beatriz Rosales Morales, Ramón Espinoza Pérez, Jorge David Cancino López, Evelin Reyes Díaz, Maya Jazmín Chacón Pérez, Paloma Arleth Zavalza Camberos, María del Carmen Ambrosio Cheng, Héctor Arturo Cedillo Galindo, María Alejandra Morinelli Astorquizaga, Miguel Ángel Trejo Villeda, Ramón Paniagua Sierra, Juan Carlos H Hernández-Rivera,

Dialysis and Renal Disease Management

Renal transplantation presents multiple complications after its completion, some of them related to the behavior of hemoglobin levels. The objective of this study is to determine the behavior and prevalence of anemia and erythrocytosis in the first year after renal transplantation. A retrospective, observational study was conducted of a cohort of patients of the 21st Century National Medical Center in Mexico of transplants performed from January 1, 2013 to December 31, 2017. A total of 649 met the inclusion criteria. Pre-transplant hemoglobin (Hb) levels were determined, as well as levels 1 month, 3, 6, 9, and 12 months after transplantation, and the prevalence of anemia and erythrocytosis was determined in each month. Descriptive analysis was performed with measures of central tendency and measures of dispersion. The statistical program SPSS version 25 was used. The mean pre-transplant Hb was 10.69 g/dL (standard deviation [SD] 2.04). One year after the renal transplant, Hb averaged 14.45 g/dL (SD 2.30), which meant an increase over the first year after renal transplantation of 3.76 g/dL. Pre-transplant anemia occurred in 73.1% of patients, and erythrocytosis in 0.1%; 12.9% of patients and 5.9% in erythrocytosis continued with anemia for a year. Renal transplantation allows Hb levels to recover in a multifactorial way; however, the persistence of anemia and erythrocytes creates a study challenge in any transplant unit, due to their prevalence of 12.9 and 5.9% respectively